Radioluminescence-based fibre-optic dosimeters in radiotherapy: a review (incl. HYPERSCINT)

1. Small-Field Dosimetry, 2. Adaptive-RT (ex. MR-LINAC), 3. Treatment Plan (End-to-End) QA, 4. FLASH-RT / UHDR, 5. In Vivo Dosimetry, 6. Brachytherapy, 7. Commissioning, 8. Cherenkov Dosimetry, 9. Advanced Dosimetry, kV Photon, MeV Electron, MV Photon, Proton (and other Particules), Adaptive-RT, Advanced Optical Dosimetry, Custom Probe Development, Detector comparaison, Fundamental Research, LINAC Pulse Discrimination, Multi-point Dosimetry, Quality Assurance, Real-time Dosimetry Show more

In their comprehensive review, Veronese et al. examine the evolution and clinical application of radioluminescence-based fiber-optic dosimeters (FODs) in radiotherapy. These dosimeters have become essential tools in modern radiotherapy due to their capability for real-time, high-resolution dose measurements with minimal perturbation of the radiation field.

The authors discuss a wide range of scintillating materials, their properties, and dosimetric performance. They provide a thorough comparison of various solutions for addressing the stem-effect, a critical issue in fiber-optic dosimetry. Solutions reviewed include the hyperspectral approach (utilized by Medscint’s HYPERSCINT system), twin-fiber subtraction, optical filtering, dual-channel spectral discrimination, temporal gating, air-core light guides, and real-time Optically Stimulated Luminescence (rtOSL). Notably, the hyperspectral technology employed by HYPERSCINT represents a major advancement, effectively overcoming many limitations of other approaches by offering superior accuracy, simplified calibration procedures, and enhanced robustness, particularly valuable in complex clinical scenarios.

The review also emphasizes the growing adoption and diverse clinical applications of FODs, highlighting their significant role in improving treatment precision and patient safety. Clinical applications addressed in the review include small-field dosimetry, brachytherapy and in vivo dosimetry; advanced radiotherapy modalities such as intensity-modulated radiation therapy (IMRT), magnetic resonance-guided radiotherapy (MRgRT), hadron and proton therapies; and finally a special attention to MRI-Linac dosimetry and ultra-high dose rate (UHDR) or FLASH radiotherapy.

Radiation Measurements
Ivan Veronese (1), Claus E. Andersen (2), Enbang Li (3), Levi Madden (4), Alexandre M.C. Santos (5, 6, 7) | Department of Physics, University of Milan and National Institute for Nuclear Physics, Milano Unit, Italy, Department of Health Technology, Technical University of Denmark, Denmark, School of Physics, Faculty of Engineering and Information Sciences, University of Wollongong, Australia, Northern Sydney Cancer Centre, Royal North Shore Hospital, Australia, Australian Bragg Centre for Proton Therapy and Research, Australia, Radiation Oncology, Central Adelaide Local Heath Network, Australia, School of Physics, Chemistry and Earth Sciences, The University of Adelaide, Australia

Temporal, spatial, and motion-included scintillation-based QA for an MR-linac

2. Adaptive-RT (ex. MR-LINAC), 3. Treatment Plan (End-to-End) QA, 7. Commissioning, 9. Advanced Dosimetry, MeV Electron, MV Photon, Adaptive-RT, Multi-point Dosimetry, Phantom QA, Quality Assurance, Real-time Dosimetry Show more

Modern adaptive radiotherapy techniques enhance healthy tissue sparing but introduce increased treatment complexity, requiring precise dosimetric validation. To address this, the MRI⁴ᴰ scintillator cassette in collaboration with IBA QUASAR and MEDSCINT is an innovative device integrating four MR-compatible plastic scintillation detectors (PSDs) and a radiochromic film. This device seamlessly works with the IBA QUASAR MRI⁴ᴰ Motion Phantom for comprehensive spatial, temporal, and motion-included dosimetry.

In this webinar, Prescilla Uijtewaal, PhD
explains her experience with the solution, showcasing the performance of the HYPERSCINT RP-200 scintillation dosimetry research platform in a 1.5T MR-linac and demonstrate the capabilities of the MRI⁴ᴰ scintillator cassette, and more.

WEBINAR – Physics World Magazine
Prescilla Uijtewaal, Martin Fast | University Medical Center Utrecht (UMCU) – Netherlands

Development and first implementation of a novel multi-modality cardiac motion and dosimetry phantom for radiotherapy applications

2. Adaptive-RT (ex. MR-LINAC), 3. Treatment Plan (End-to-End) QA, MV Photon, Adaptive-RT, Multi-point Dosimetry, Phantom QA, Quality Assurance, Real-time Dosimetry Show more

Magnetic resonance guided radiation therapy (MRgRT) for real-time gating around the heart for treating ventricular tachycardia (VT) are rapidly advancing. A novel, multi-modality modular heart phantom was developed and utilized in gated radiotherapy experiments on a 0.35 T MR-linac. This phantom can simulate cardiac, cardio-respiratory, and respiratory motions, and perform dosimetric evaluations using ionization chamber and plastic scintillation detectors (PSD from MEDSCINT) configurations.

Due to their small sensitive volumes, time-resolved PSDs are effective for low-amplitude/high-frequency movements and multi-point data acquisition, enhancing dosimetric capabilities. This advancement in VT planning and delivery illustrates the phantom’s potential to meet the growing demands of cardiac applications in radiotherapy.

MEDICAL PHYSICS
Kenneth W. Gregg (1,2), Chase Ruff (1,2), Grant Koenig (3), Kalin I. Penev (3), Andrew Shepard (1), Grace Kreissler (4), Margo Amatuzio (4), Cameron Owens (4), Prashant Nagpal (5), Carri K. Glide-Hurst (1,2) | 1. Department of Human Oncology, University of Wisconsin–Madison, Madison, Wisconsin, USA, 2. Department of Medical Physics, University of Wisconsin–Madison, Madison, Wisconsin, USA, 3. Modus Medical Devices, Inc. (IBA QUASAR),London, Ontario, Canada, 4. Department of Biomedical Engineering, University of Wisconsin–Madison, Madison, Wisconsin, USA, 5. Department of Radiology, University of Wisconsin–Madison, Madison, Wisconsin, USA

MLC tracking and dose accumulation validation on the MR-linac using a real-time deformable dosimeter

2. Adaptive-RT (ex. MR-LINAC), 3. Treatment Plan (End-to-End) QA, MV Photon, Adaptive-RT, Commissioning, Multi-point Dosimetry, Phantom QA, Quality Assurance, Real-time Dosimetry Show more

Online MRI on the MR-linac captures detailed anatomical movements, improving real-time radiotherapy adaptations. However, the lack of a suitable MRI-compatible phantom hinders workflow validation. This study introduces a deformable phantom with integrated real-time scintillation dosimeters, validating accuracy in MLC tracking and dose accumulation using the ELEKTA Unity MR-linac.

This study demonstrates the vast potential of this novel prototype deformable phantom with integrated PSDs for real-time dosimetry measurements on an MR-linac.

2024 ESTRO Annual Congress
Madelon van den Dobbelsteen (1), Pim T.S. Borman (1), Laurie J.M. de Vries (1), Sara L. Hackett (1), Kalin Penev (1), Rocco Flores (2), Stephanie Smith (2), Yoan LeChasseur (3), Simon Lambert-Girard (3), Benjamin Côté (3) , Peter L. Woodhead (1)(4), Lando S. Bosma (1), Cornel Zachiu (1), Bas W. Raaymakers (1), Martin F. Fast (1) | 1 University Medical Center Utrecht, Radiotherapy, Utrecht, Netherlands., 2 IBA QUASAR, Modus Medical Devices Inc. London ON, Canada. , 3 Medscint, -, Quebec City, Canada. , 4 Elekta AB, -, Stockholm, Sweden.

Development of End-to-End Preclinical Treatment Verification Procedures, Traceable to NPL Air Kerma Primary Standard

1. Small-Field Dosimetry, 3. Treatment Plan (End-to-End) QA, 5. In Vivo Dosimetry, kV Photon, Adaptive-RT, Fundamental Research, Phantom QA, Quality Assurance, Rabiobiology, Real-time Dosimetry Show more

Dosimetry audits are an important tool to improve quality of reported results and to support standardization of preclinical radiation research. This work presents how the combination of passive and active detectors, such as the real-time HYPERSCINT scintillation dosimetry solution, with anatomically correct mouse phantoms are adequate for the development of End-to-End dosimetry audits for the independent verification of preclinical radiation treatments.

The traceability of the detectors’ calibration to primary standards strengthens the dosimetry chain in the validation of preclinical plans, and it is consistent with the current practice for dose traceability of clinical radiotherapy treatments. Their implementation at national and regional levels could lead to databases of anonymised records, which will positively impact the dissemination of best practices and sharing of validated results.

6th Conference on small animal precision image-guided radiotherapy
Ileana Silvestre Patallo (1), Rebecca Carter (2)(3), Andrew Nisbet (2), Anna Subiel (1), Giuseppe Schettino (1) | 1. National Physical Laboratory, UK, 2. University College London, UK, 3. Cancer Institut, UK

Performance characterization of a novel hybrid dosimetry insert for simultaneous spatial, temporal, and motion-included dosimetry for MR-linac

2. Adaptive-RT (ex. MR-LINAC), 3. Treatment Plan (End-to-End) QA, 7. Commissioning, MeV Electron, MV Photon, Adaptive-RT, Commissioning, Multi-point Dosimetry, Phantom QA, Real-time Dosimetry Show more

The increased treatment complexity and the motion-delivery interplay during stereotactic body radiotherapy (SBRT) on an MR-linac treatments require MR-compatible motion phantoms with time-resolved dosimeters to validate end-to-end workflows. This study demonstrates the excellent suitability of a the Medscint novel hybrid film-scintillators cassette for simultaneous multi-spatial, temporal, and motion-included dosimetry.

MEDICAL PHYSICS
Prescilla Uijtewaal (1), Pim Borman (1), Benjamin Côté (2), Yoan LeChasseur (2), François Therriault-Proulx (2), Rocco Flores (3), Stephanie Smith (3), Grant Koenig (3), Bas Raaymakers (1), Martin Fast (1) | 1. Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands, 2. Medscint, Québec, Quebec, Canada, 3. Modus QA, London, Ontario, Canada

Performance of the HYPERSCINT scintillation dosimetry research platform for the 1.5 T MR-linac

2. Adaptive-RT (ex. MR-LINAC), 3. Treatment Plan (End-to-End) QA, MV Photon, Adaptive-RT, Angular dependancy, Detector comparaison, Energy Dependency, Quality Assurance, Real-time Dosimetry Show more

This study demonstrates the suitability of the HYPERSCINT PSD for accurate time- resolved dosimetry measurements in the 1.5 T MR-linac. The excellent performance during continuous MR scanning and during dynamic movement indicates the great potential of the detector to validate end-to-end workflows of online adaptive radiotherapy

PHYSICS IN MEDICINE & BIOLOGY
Prescilla Uijtewaal (1), Benjamin Côté (2), Thomas Foppen (1), J H Wilfred de Vries (1), Simon J Woodings (1), Pim T S Borman (1), Simon Lambert-Girard (2), François Therriault-Proulx (2), Bas W Raaymakers (1), Martin F Fast (1) | 1 – UMC Utrecht, Netherland, 2 – Medscint, Canada

Plastic scintillation detectors: real-time dosimetry in the MR-Linac environment.

2. Adaptive-RT (ex. MR-LINAC), 3. Treatment Plan (End-to-End) QA, 9. Advanced Dosimetry, MV Photon, Adaptive-RT, Fundamental Research, Multi-point Dosimetry, Real-time Dosimetry Show more

Optical innovation meets clinical translation : in the vanguard of adaptive MR/RT research effort, the UMC Utrecht research team works with plastic scintillation detectors to bring MR-Linac treatment to the next level.

PHYSICS WORLD
| UMC Utrecht, Medscint

Patient Specific QA for External Beam Radiotherapy Using the HYPERSCINT Plastic Scintillation Detector

3. Treatment Plan (End-to-End) QA, MV Photon, Detector comparaison, Phantom QA, Quality Assurance Show more

Plastic scintillation detectors have interesting dosimetric properties, including small size and energy independence. These advantages make them well suited for VMAT patient-specific QA, either alone or in conjunction with a detector matrix. This work aims to determine if the HYPERSCINT scintillation dosimetry research platform can replace the classic ion chamber in a clinical patient-specific QA workflow.

2020 AAPM AM
M.Goulet | CISSS – Chaudiere-Appalaches, Lévis, QC, CA